Effects of testosterone and growth hormone on the structural and mechanical properties of bone by micro-mri in the distal tibia of men with hypopituitarism

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 4, 2014, Pages 1236-1244

  Mukaddam, Mona Al ^a   Rajapakse, Chamith S ^b   Bhagat, Yusuf A ^b,e   Wehrli, Felix W ^b   Guo, Wensheng ^b   Peachey, Helen ^a   LeBeau, Shane O ^a,f   Zemel, Babette S ^c   Wang, Christina ^d   Swerdloff, Ronald S ^d   Kapoor, Shiv C ^a   Snyder, Peter J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^e Samsung RandD Institute America   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; ESTRADIOL; HUMAN GROWTH HORMONE; HUMATROPEN; PARATHYROID HORMONE; SOMATOMEDIN C; TESTOSTERONE; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ADULT; AGED; ANDROGEN DEFICIENCY; ANDROGEN THERAPY; ARTICLE; BIOMECHANICS; BONE MASS; BONE STRENGTH; BONE STRUCTURE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORTICAL BONE; CORTICAL THICKNESS (BONE); DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; MALE; MONOTHERAPY; MUSCULOSKELETAL SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE MICROIMAGING; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; TIBIA; TRABECULAR BONE; TRABECULAR THICKNESS;

ADULT; AGED; BIOMECHANICAL PHENOMENA; BONE AND BONES; BONE DENSITY; GROWTH HORMONE; HUMANS; HYPOPITUITARISM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TESTOSTERONE; TIBIA;

EID: 84898406894     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3665     Document Type: Article

References (40)

1. Greenspan SL, Coates P, Sereika SM, Nelson JB, Trump DL, Resnick NM. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab. 2005; 90:6410-6417.
2. Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 1989;69:523-527.
3. Wadhwa VK, Weston R, Mistry R, Parr NJ. Long-term changes in bone mineral density and predicted fracture risk in patients receiving andro-gen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values. BJU Int. 2009;104:800-805.
4. Hamilton EJ, Ghasem-Zadeh A, Gianatti E, et al. Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy. J Clin Endocrinol Metab. 2010;95: E456-E463.
5. Benito M, Gomberg B, Wehrli FW, et al. Deterioration of trabecular architecture in hypogonadal men. J Clin Endocrinol Metab. 2003; 88:1497-1502.
6. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. NEngl J Med. 2005; 352:154-164.
7. Smith MR, Lee WC, Brandman J, Wang Q, Botteman M, Pashos CL. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer. J Clin Oncol. 2005;23:7897-7903.
8. Snyder PJ, Peachey H, Berlin JA, et al. Effects of testosterone replacement in hypogonadal men. JClin Endocrinol Metab. 2000;85: 2670-2677.
9. Leifke E, Korner HC, Link TM, Behre HM, Peters PE, Nieschlag E. Effects of testosterone replacement therapy on cortical and trabec-ular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol. 1998;138:51-58.
10. Benito M, VasilicB, Wehrli FW, et al. Effect of testosterone replacement on trabecular architecture in hypogonadal men. JBone Miner Res. 2005;20:1785-1791.
11. Zhang XH, Liu XS, Vasilic B, et al. In vivo microMRI-based finite element and morphological analyses of tibial trabecular bone in eugonadal and hypogonadal men before and after testosterone treatment. J Bone Miner Res. 2008;23:1426-1434.
12. Khosla S, Melton LJ 3rd, Riggs BL. Clinical review 144: Estrogen and the male skeleton. J Clin Endocrinol Metab. 2002;87:1443-1450.
13. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest. 2000;106:1553-1560.
14. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003;88:204-210.
15. Tritos NA, Greenspan SL, King D, et al. Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis. J Clin Endocrinol Metab. 2011;96:1516-1523.
16. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol. 1997;137:240-245.
17. Wuster C, Abs R, Bengtsson BA, et al. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res. 2001;16:398-405.
18. Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial. J Bone Miner Res. 2002;17:1081-1094.
19. Baum HB, Biller BM, Finkelstein JS, et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. AnnInternMed. 1996;125:883-890.
20. Snyder PJ, Biller BM, Zagar A, et al. Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency. J Bone Miner Res. 2007;22:762-770.
21. Blackman MR, Sorkin JD, Munzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. 2002;288:2282-2292.
22. Mauras N, Rini A, Welch S, Sager B, Murphy SP. Synergistic effects of testosterone and growth hormone on protein metabolism and body composition in prepubertal boys. Metabolism. 2003;52:964-969.
23. Blok GJ, de Boer H, Gooren LJ, van der Veen EA. Growth hormone substitution in adult growth hormone-deficient men augments an-drogen effects on the skin. Clin Endocrinol (Oxf). 1997;47:29-36.
24. Wehrli FW, Rajapakse CS, Magland JF, Snyder PJ. Mechanical implications of estrogen supplementation in early postmenopausal women. J Bone Miner Res. 2010;25:1406-1414.
25. Ladinsky GA, Vasilic B, Popescu AM, et al. Trabecular structure quantified with the MRI-based virtual bone biopsy in postmeno-pausal women contributes to vertebral deformity burden independent of areal vertebral BMD. J Bone Miner Res. 2008;23:64-74.
26. Wehrli FW, Gomberg BR, Saha PK, Song HK, Hwang SN, Snyder PJ. Digital topological analysis of in vivo magnetic resonance microimages of trabecular bone reveals structural implications of osteoporosis. J Bone Miner Res. 2001;16:1520-1531.
27. Rajapakse CS, Magland JF, Wald MJ, et al. Computational biome-chanics of the distal tibia from high-resolution MR and micro-CT images. Bone. 2010;47:556-563.
28. Rajapakse CS, Leonard MB, Bhagat YA, Sun W, Magland JF, Wehrli FW. Micro-MR imaging-based computational biome-chanics demonstrates reduction in cortical and trabecular bone strength after renal transplantation. Radiology. 2012;262:912-920.
29. Biller BM, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. JClin Endocrinol Metab. 2002;87:2067-2079.
30. Shiraishi S, Lee PW, Leung A, Goh VH, Swerdloff RS, Wang C. Simultaneous measurement of serum testosterone and dihydrotes-tosterone by liquid chromatography-tandem mass spectrometry. Clin Chem. 2008;54:1855-1863.
31. Rothman MS, Carlson NE, Xu M, et al. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatog-raphy-tandem mass spectrometry. Steroids. 2011;76:177-182.
32. Magland JF, Wald MJ, Wehrli FW. Spin-echo micro-MRI of tra-becular bone using improved 3D fast large-angle spin-echo (FLASE). Magn Reson Med. 2009;61:1114-1121.
33. Song HK, Wehrli FW. In vivo micro-imaging using alternating navigator echoes with applications to cancellous bone structural analysis. Magn Reson Med. 1999;41:947-953.
34. Lin W, Ladinsky GA, Wehrli FW, Song HK. Image metric-based correction (autofocusing) of motion artifacts in high-resolution tra-becular bone imaging. JMagn Reson Imaging. 2007;26:191-197.
35. Vasilic B, Wehrli FW. A novel local thresholding algorithm for tra-becular bone volume fraction mapping in the limited spatial resolution regime of in vivo MRI. IEEE Trans Med Imaging. 2005;24: 1574-1585.
36. Saha PK, Wehrli FW. Measurement of trabecular bone thickness in the limited resolution regime of in vivo MRI by fuzzy distance transform. IEEE Trans Med Imaging. 2004;23:53-62.
37. Zysset PK, Guo XE, Hoffler CE, Moore KE, Goldstein SA. Elastic modulus and hardness of cortical and trabecular bone lamellae measured by nanoindentation in the human femur. J Biomech. 1999; 32:1005-1012.
38. Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroid hormone and alendronate alone or in combination in post-menopausal osteoporosis. N Engl J Med. 2003;349:1207-1215.
39. Stein EM, Liu XS, Nickolas TL, et al. Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. JBone Miner Res. 2010;25:2572-2581.
40. Hansen S, Hauge EM, Beck Jensen JE, Brixen K. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Miner Res. 2013;28:736-745.